Abstract

Adiponectin is an adipose-derived hormone that plays an important role in maintaining energy homeostasis. Adiponectin gene expression is diminished in both obesity and type 2 diabetes. However, the mechanism underlying the impaired adiponectin gene expression remains poorly understood. Recent studies have indicated that forkhead transcription factor O1 (Foxo1) and silent information regulator 2 mammalian ortholog SIRT1 are involved in adipogenesis. Here we have shown that Foxo1 up-regulates adiponectin gene transcription through a Foxo1-responsive region in the mouse adiponectin promoter that contains two adjacent Foxo1 binding sites. Foxo1 interacts with CCAAT/enhancer-binding protein alpha (C/EBPalpha) to form a transcription complex at the mouse adiponectin promoter and up-regulates adiponectin gene transcription. Our study has revealed that C/EBPalpha accesses the adiponectin promoter through two Foxo1 binding sites and acts as a co-activator. Further, SIRT1 increases adiponectin transcription in adipocytes by activating Foxo1 and enhancing Foxo1 and C/EBPalpha interaction. Importantly, both Foxo1 and SIRT1 protein levels were significantly lower in epididymal fat tissues from db/db and high fat diet-induced obese mice compared with normal mice. We propose that low expression of SIRT1 and Foxo1 leads to impaired Foxo1-C/EBPalpha complex formation, which contributes to the diminished adiponectin expression in obesity and type 2 diabetes.

Highlights

  • Information is limited regarding the underlying mechanisms that impair adiponectin gene expression in obesity and type 2 diabetes

  • Foxo1 Up-regulates Adiponectin Gene Expression in Differentiated Adipocytes—Foxo1 expression is induced in the early stages of adipocyte differentiation, but its activation is delayed until the end of the clonal expansion [8], which suggests that Foxo1 regulates adipogenesis in a stage-dependent manner

  • The results clearly showed that adiponectin protein and RNA levels were significantly increased in adipocytes transduced by adenovirus vector encoding Foxo1-WT or Foxo1-ADA (p Ͻ 0.05) (Fig. 1, A and B)

Read more

Summary

Introduction

Information is limited regarding the underlying mechanisms that impair adiponectin gene expression in obesity and type 2 diabetes. The expression of Foxo and SIRT1 is up-regulated during adipocyte differentiation [8, 9]. SIRT1 regulates Foxo transactivation activity by deacetylating three lysine residues within the forkhead DNA binding domain [12]. These studies led us to hypothesize that Foxo and SIRT1 may regulate adiponectin gene expression. We report that overexpression of Foxo increased adiponectin gene expression in differentiated 3T3-L1 adipocytes. Expression of SIRT1 synergistically increased Foxo1- and C/EBP␣-mediated adiponectin promoter activation. We conclude that SIRT1 up-regulates adiponectin gene transcription via a Foxo1-C/ EBP␣ transcription complex. The study suggests that decreased expression of SIRT1 and Foxo in obesity may play a causal role in the diminished adiponectin gene expression

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call